We are live on ! Find out more
PAVM icon

PAVmed
PAVM

15 hedge funds and large institutions have $3.2M invested in PAVmed in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

152% more capital inflows, than outflows

Capital inflows: $126K | Capital outflows: $49.9K

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.31% less ownership

Funds ownership: 6.59% → 6.28% (-0.31%)

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Levin Capital Strategies
Levin Capital Strategies
New York
+$46.2K
2
Virtu Financial
Virtu Financial
New York
+$19.2K
3
UBS Group
UBS Group
Switzerland
+$17.9K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$15.8K
5
BlackRock
BlackRock
New York
+$13.3K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$26K
2
Moloney Securities Asset Management
Moloney Securities Asset Management
Missouri
-$11K
3
Bank of America
Bank of America
North Carolina
-$6K
4
Victory Capital Management
Victory Capital Management
Texas
-$4K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.92K

PAVM Hedge Fund Activity: Q4 2019 in Review

15 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2019, worth a combined $3.2M — up 25% from $2.55M a quarter earlier.

Fund positioning in PAVM was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $46.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26K sold.

  • 15 institutional investors held PAVmed (PAVM) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $3.2M of PAVmed stock for Q4 2019, up 25% quarter-over-quarter.
  • 4 funds opened new PAVmed positions in Q4 2019 and 4 closed out, a net change of 0 holders.
  • The largest PAVmed buyer in Q4 2019 was Levin Capital Strategies, an estimated $46.2K added.
  • The largest PAVmed seller in Q4 2019 was Citadel Advisors, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2019.